BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAK7 Class: NOTE 1.250% 5/1

Wellesley Asset Management's Holding History (CIK: 0001533551)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,058,000 Value ($000) $3,900 Avg Close Range
Q3 2025
Shares 26,963,000 Value ($000) $25,612 Avg Close Range
Q2 2025
Shares 50,624,000 Value ($000) $47,710 Avg Close Range
Q1 2025
Shares 52,084,000 Value ($000) $49,179 Avg Close Range
Q4 2024
Shares 56,960,000 Value ($000) $53,058 Avg Close Range
Q3 2024
Shares 56,105,000 Value ($000) $53,487 Avg Close Range
Q2 2024
Shares 57,124,913 Value ($000) $54,965 Avg Close Range
Q1 2024
Shares 42,699,000 Value ($000) $42,517 Avg Close Range
Q4 2023
Shares 40,519,270 Value ($000) $41,871 Avg Close Range
Q3 2023
Shares 7,972,480 Value ($000) $7,799 Avg Close Range
Q2 2023
Shares 42,526,167 Value ($000) $42,984 Avg Close Range
Q1 2023
Shares 32,443,000 Value ($000) $33,720 Avg Close Range
Q4 2022
Shares 52,096 Value ($000) $56 Avg Close Range
Q3 2022
Shares 52,002 Value ($000) $52,121 Avg Close Range
Q2 2022
Shares 50,586 Value ($000) $50,777 Avg Close Range
Q1 2022
Shares 30,062 Value ($000) $30,276 Avg Close Range
Q4 2021
Shares 45,919 Value ($000) $47,842 Avg Close Range
Q3 2021
Shares 32,795 Value ($000) $32,986 Avg Close Range